5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with erythromycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frees, D; Ingmer, H; Larsen, TO; Nielsen, A; Nielsen, KF | 1 |
| Mardones, G; Venegas, A | 1 |
2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and erythromycin
| Article | Year |
|---|---|
Method for screening compounds that influence virulence gene expression in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Galactosidase; Drug Evaluation, Preclinical; Fungi; Gene Expression Regulation, Bacterial; Glucose; Lac Operon; Quorum Sensing; RNA, Bacterial; Staphylococcus aureus; Trans-Activators; Virulence Factors | 2010 |
Chromogenic plate assay distinguishing bacteriolytic from bacteriostatic activity of an antibiotic agent.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteriolysis; beta-Galactosidase; Chromogenic Compounds; Enterobacteriaceae; Erythromycin; Galactosides; Hydrolysis; Indoles; Isopropyl Thiogalactoside; Microbial Sensitivity Tests; Penicillins; Peptides; Reproducibility of Results; Tetracycline | 2000 |